(CCK) Crown Holdings - Overview
Stock: Aluminum Cans, Beverage Ends, Food Cans, Aerosol Cans, Transit Packaging
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.08% |
| Yield on Cost 5y | 1.17% |
| Yield CAGR 5y | 6.78% |
| Payout Consistency | 28.7% |
| Payout Ratio | 13.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.9% |
| Relative Tail Risk | -8.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.01 |
| Alpha | 23.66 |
| Character TTM | |
|---|---|
| Beta | 0.548 |
| Beta Downside | 0.566 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.73% |
| CAGR/Max DD | 0.46 |
Description: CCK Crown Holdings January 02, 2026
Crown Holdings Inc. (NYSE: CCK) is a global manufacturer of metal, glass, and plastic packaging, organized into four geographic segments: Americas Beverage, European Beverage, Asia Pacific, and Transit Packaging. Its product portfolio includes recyclable aluminum beverage cans, steel crowns, aluminum caps, non-beverage cans, food and aerosol cans, as well as a range of consumables (e.g., straps, films, airbags) and the equipment needed to apply and remove them. The company serves a diversified customer base spanning beverage, food, pet-food, personal-care, household, and industrial sectors.
Key quantitative points (as of FY 2024) include: • Revenue of roughly $13 billion, with a 5-year compound annual growth rate (CAGR) of 3.2% driven largely by expanding beverage volumes in emerging markets. • EBITDA margin around 13%, reflecting stable pricing power in aluminum cans but sensitivity to raw-material cost volatility (aluminum and steel prices). • Capital intensity is modest; capex averaged $250 million per year, primarily for plant upgrades to improve recycling efficiency. Economic drivers include global trends toward sustainable packaging (regulatory mandates on recyclability) and the cyclical nature of commodity prices, which can compress margins if input costs rise faster than product pricing.
For a deeper quantitative view, the ValueRay platform offers a granular breakdown of CCK’s valuation metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 737.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.00 > 1.0 |
| NWC/Revenue: 0.99% < 20% (prev 6.32%; Δ -5.33% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.51b > Net Income 737.0m |
| Net Debt (5.20b) to EBITDA (2.01b): 2.58 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (114.2m) vs 12m ago -3.68% < -2% |
| Gross Margin: 18.34% > 18% (prev 0.22%; Δ 1813 % > 0.5%) |
| Asset Turnover: 87.94% > 50% (prev 85.22%; Δ 2.73% > 0%) |
| Interest Coverage Ratio: 3.91 > 6 (EBITDA TTM 2.01b / Interest Expense TTM 398.0m) |
Altman Z'' 1.98
| A: 0.01 (Total Current Assets 4.39b - Total Current Liabilities 4.27b) / Total Assets 14.27b |
| B: 0.27 (Retained Earnings 3.86b / Total Assets 14.27b) |
| C: 0.11 (EBIT TTM 1.56b / Avg Total Assets 14.06b) |
| D: 0.28 (Book Value of Equity 3.00b / Total Liabilities 10.79b) |
| Altman-Z'' Score: 1.98 = BBB |
Beneish M -2.87
| DSRI: 1.01 (Receivables 1.77b/1.67b, Revenue 12.37b/11.80b) |
| GMI: 1.17 (GM 18.34% / 21.52%) |
| AQI: 1.01 (AQ_t 0.33 / AQ_t-1 0.33) |
| SGI: 1.05 (Revenue 12.37b / 11.80b) |
| TATA: -0.05 (NI 737.0m - CFO 1.51b) / TA 14.27b) |
| Beneish M-Score: -2.87 (Cap -4..+1) = A |
What is the price of CCK shares?
Over the past week, the price has changed by +7.83%, over one month by +8.54%, over three months by +17.53% and over the past year by +30.62%.
Is CCK a buy, sell or hold?
- StrongBuy: 8
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CCK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 123.4 | 9.3% |
| Analysts Target Price | 123.4 | 9.3% |
| ValueRay Target Price | 116.1 | 2.8% |
CCK Fundamental Data Overview February 07, 2026
P/E Forward = 13.9276
P/S = 1.085
P/B = 4.4324
P/EG = 0.6556
Revenue TTM = 12.37b USD
EBIT TTM = 1.56b USD
EBITDA TTM = 2.01b USD
Long Term Debt = 5.78b USD (from longTermDebt, two quarters ago)
Short Term Debt = 563.0m USD (from shortTermDebt, last quarter)
Debt = 5.96b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.20b USD (from netDebt column, last quarter)
Enterprise Value = 18.37b USD (13.17b + Debt 5.96b - CCE 764.0m)
Interest Coverage Ratio = 3.91 (Ebit TTM 1.56b / Interest Expense TTM 398.0m)
EV/FCF = 16.73x (Enterprise Value 18.37b / FCF TTM 1.10b)
FCF Yield = 5.98% (FCF TTM 1.10b / Enterprise Value 18.37b)
FCF Margin = 8.88% (FCF TTM 1.10b / Revenue TTM 12.37b)
Net Margin = 5.96% (Net Income TTM 737.0m / Revenue TTM 12.37b)
Gross Margin = 18.34% ((Revenue TTM 12.37b - Cost of Revenue TTM 10.10b) / Revenue TTM)
Gross Margin QoQ = 10.30% (prev 18.99%)
Tobins Q-Ratio = 1.29 (Enterprise Value 18.37b / Total Assets 14.27b)
Interest Expense / Debt = 1.59% (Interest Expense 95.0m / Debt 5.96b)
Taxrate = 26.64% (73.0m / 274.0m)
NOPAT = 1.14b (EBIT 1.56b * (1 - 26.64%))
Current Ratio = 1.03 (Total Current Assets 4.39b / Total Current Liabilities 4.27b)
Debt / Equity = 1.99 (Debt 5.96b / totalStockholderEquity, last quarter 3.00b)
Debt / EBITDA = 2.58 (Net Debt 5.20b / EBITDA 2.01b)
Debt / FCF = 4.74 (Net Debt 5.20b / FCF TTM 1.10b)
Total Stockholder Equity = 2.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.24% (Net Income 737.0m / Total Assets 14.27b)
RoE = 25.41% (Net Income TTM 737.0m / Total Stockholder Equity 2.90b)
RoCE = 17.96% (EBIT 1.56b / Capital Employed (Equity 2.90b + L.T.Debt 5.78b))
RoIC = 12.28% (NOPAT 1.14b / Invested Capital 9.31b)
WACC = 5.82% (E(13.17b)/V(19.14b) * Re(7.93%) + D(5.96b)/V(19.14b) * Rd(1.59%) * (1-Tc(0.27)))
Discount Rate = 7.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.33%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈974.4m ; Y1≈639.6m ; Y5≈291.8m
Fair Price DCF = 36.14 (EV 9.30b - Net Debt 5.20b = Equity 4.10b / Shares 113.4m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 16.22 | EPS CAGR: -3.77% | SUE: 0.21 | # QB: 0
Revenue Correlation: -29.50 | Revenue CAGR: -0.30% | SUE: 1.53 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.72 | Chg30d=+0.014 | Revisions Net=+2 | Analysts=11
EPS current Year (2026-12-31): EPS=8.22 | Chg30d=-0.016 | Revisions Net=-5 | Growth EPS=+5.5% | Growth Revenue=+1.4%
EPS next Year (2027-12-31): EPS=9.00 | Chg30d=-0.010 | Revisions Net=-2 | Growth EPS=+9.5% | Growth Revenue=+3.1%